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Edited by Gianni CesareniAbstract The transcription factor ecotropic viral integration
site 1 (Evi1) is associated with acute myeloid leukemia (AML)
and myelodysplastic syndrome (MDS) in patients due to
chromosomal aberration of chromosome 3. Here we show that
Evi1 interacts with the histone methyltransferase SUV39H1.
The interaction requires the N-terminal part of Evi1 and the
H3-speciﬁc histone methyltransferase domain, SET, of
SUV39H1 without Evi1 having an inhibitory eﬀect on SUV39H1
methyltransferase activity. Presence of SUV39H1 enhances Evi1
transcriptional repression in a dose dependent manner. In addi-
tion, Evi1 also interacts with another histone methyltransferase,
G9a, but not with SET9. Our data establish an epigenetic role of
Evi1 in cell transformation by recruiting higher order chromatin
remodeling complexes.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ecotropic viral integration site 1 (Evi1) encodes a zinc ﬁnger
transcriptional regulator which has been identiﬁed as a com-
mon virus integration site in murine leukemia [1]. In humans,
aberrant expression of Evi1 has been observed in myeloprolif-
erative disorders including myelodysplastic syndrome (MDS)
and acute myeloid leukemia (AML), particularly in patients
with translocations or inversions involving chromosome 3q26
[2]. In vitro and in vivo studies support the notion that inap-
propriate expression of Evi1 plays a critical role in the develop-
ment of MDS and AML. Overexpression of Evi1 blocks the
diﬀerentiation of myeloid progenitor cell line 32Dcl3 towards
mature neutrophils [3], whereas in early erythroid lineage cell
line model 32DEpo1 overexpression of Evi1 diminishes eryth-
ropoietin sensitivity [4].
Evi1 contains two DNA binding motifs. The N-terminal
part of the protein possesses a domain containing seven zinc
ﬁngers, which recognizes GACAAGATAA(GATAA) nucleo-
tide sequences, whereas a region of three zinc ﬁngers at the
C-terminus binds GAAGATGAG sequences [5–7]. One of
the possible mechanisms that may explain the oncogenic eﬀect*Corresponding author. Fax: +31 10 4089470.
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get genes [8,9]. Another possible mechanism of transformation
may be through complex formation with other proteins that
are critical for transcriptional regulation. In fact, Evi1 has
been shown to interact with several transcriptional regulators
like Smad3, HDACs, and CtBP, to mediate transcriptional
repression [10–14].
In recent years, the interest in post-translational modiﬁca-
tions of histone tails has unveiled the important role of chro-
matin remodeling in transcriptional regulation. Modiﬁcations
at speciﬁc histone residues have important biological eﬀects
on transcription [15]. Methylation has been one of the ﬁrst
modiﬁcations shown to play an important role in chromatin
regulation. Histone H3 methylation at diﬀerent lysine residues
by speciﬁc methyltransferases has been linked to activation
and silencing of transcription [16–18]. The ﬁrst protein demon-
strated to possess methyltransferase speciﬁcity towards histone
H3 lysine 9 (H3-K9) was the mammalian SUV39H1 enzyme, a
homologue of Schizosaccharomyces pombe Clr4 and Drosoph-
ila Su(Var)3.9 [19]. This preferential methylation of H3 de-
pends on the SET domain (Suppressor of Variegation,
Enhancer of Zeste and Trithorax [20]) of SUV39H1, a 130
amino acid domain that is conserved among diﬀerent species.
In addition to SUV39H1, several other methyltransferases
have been identiﬁed, e.g. SET7, SET9 or G9a, which display
methylation activities speciﬁc to histone H3-lysine 4, lysine 9
and lysine 27 [16–18,21].
Here we investigate whether Evi1 can form a complex with
histone methyltransferases and show that it physically interacts
with SUV39H1. This interaction involves the SET domain of
SUV39H1 and the N-terminus of Evi1. These results establish
that Evi1 can act as a transcriptional regulator that is able to
form higher order complexes with histone methyltransferases
and thereby inﬂuence the transcriptional repression of putative
target genes.2. Materials and methods
2.1. Expression constructs
A FLAG or an HA epitope tag was fused in frame with the ﬁrst
ATG of Evi1 cDNA and cloned into the pCMV mammalian expres-
sion vector (Clontech, Palo Alto, CA). All deletion mutants were gen-
erated from the original cDNA of FLAG-Evi1 using available
restriction sites (available upon request). Full length SUV39H1 and
its mutants were a kind gift from Dr. A.H. Peters (IMP, Vienna,
Austria). All SUV39H1 constructs were tagged with triple-Myc at
the amino terminus. The pCMV-FLAG-G9a expression vector was a
kind gift from Dr. I. Talianidis (Institute of Molecular Biology & Bio-
technology, Crete, Greece) and has been described previously [22]. Theblished by Elsevier B.V. All rights reserved.
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Fig. 1. Evi1 interacts with SUV39H1 via its N-terminal zinc ﬁnger domain. (A) Schematic representation of SUV39H1 and Evi1. Protein extracts
from cells transiently transfected with Myc-SUV39H1 and HA-Evi1 constructs were immunoprecipitated with anti-Myc (left panel) or anti-HA (right
panel) antibodies followed by Western blot (WB) analysis. In control experiments, immunoprecipitations were performed with lysates that were
transfected with HA-Evi1 alone (left panel) or Myc-SUV39H1 alone (right panel). Ten percent of total protein lysates were used as input for WB. (B)
Cells were co-transfected with Myc-SUV39H1 and HA-Evi1 and stained with anti-Myc and anti-HA antibodies followed by secondary TRITC (Red)
and FITC (Green) staining, respectively. Merged images revealed the association of both proteins in speckled structures of the nucleus. (C) Diagram
representing full length Evi1 and various mutants used in the mapping analysis with full length SUV39H1. Evi1 domains: zinc ﬁngers (ZF) 1–7, RD
(repression domain), ZF 8–10, AD (acidic domain). In all constructs the Tag was cloned such that it was expressed at the N-terminus of the proteins.
(D) Full length Myc-SUV39H1 was transiently transfected with full length FLAG-Evi1 or with one of its mutants. Immunoprecipitation was
performed using an anti-Myc antibody. Proteins were detected by WB analysis using an anti-FLAG antibody. Ten percent of total protein lysates
were used as input for the WB analysis and are depicted in the lower panel.
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Pfu polymerase and cloned into a pCMV-FLAG expression vector
to generate a pCMV-FLAG-SET9 construct.
2.2. Immunoprecipitation, Western Blot, protein puriﬁcation, and in vitro
histone methyltransferase (HMTase) assay
2 · 106 phoenix E (uE) cells were seeded in 100 mm dishes (Becton
Dickinson, Franklin Lakes, NJ) and cultured in Dulbeccos modiﬁed
Eagles medium (DMEM, Life Technologies, Paisley, UK) supple-
mented with 10% FCS and transfected with 20 lg DNA using calcium
phosphate co-precipitation [23]. Cells were harvested after 48 h,
washed with ice-cold PBS and lysed in ice-cold lysis buﬀer (20 mM
Tris, pH 8.0, 137 mM NaCl, 10 mM EDTA, 100 mM NaF, 1% NP-
40, 10% glycerol) containing protease inhibitor mix and Pefablock
(Roche, Zwijndrecht, NL). Protein complexes were incubated over-
night at 4 C. Proteins bound to sepharose G-beads were collected,
washed extensively with ice-cold lysis buﬀer and resuspended in 1· SDS
Laemmli buﬀer [24]. Complexes were denatured, separated on an
8–10% SDS–PAGE gel and transferred to nitrocellulose membrane
(Schleicher & Schuell, Dassel, Germany). Primary antibodies were
detected with a secondary horseradish peroxidase-conjugated antibody
(Dako Diagnostic BV, Denmark) and visualized by enhanced
chemiluminescence (ECL, Boston, MA). HMTase activity was assayed
as described previously [21]. Proteins were visualized by staining SDS–
PAGE gels with Coomassie Brilliant Blue R-250 (N.V. Life Technolo-
gies S.A., Merelbeke, NL).
2.3. Immunoﬂuorescence microscopy
COS-7 cells were grown on cover slips and transfected with equal
amount (4 lg) of Myc-SUV39H1 and HA-Evi1 constructs using the
FuGENE transfection reagent (Roche, Zwijndrecht, NL). Forty-eightMyc-ΔSET
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Fig. 2. The SET domain of SUV39H1 is required for its interaction wit
representations of SUV39H1 and its mutants. (B) Full length Myc-SUV39H1
Immunoprecipitation was performed using an anti-FLAG antibody. Proteins
of total protein lysates were used as input for WB. (C) Pull-down assays us
transfected with HA-Evi1 and Myc-SUV39H1 or HA-Evi1 alone. Proteins
determined by Ponceau S staining (bottom panel).hours post-transfection, cells were washed with cold PBS and pro-
cessed as described previously [25]. Cells were stained with anti-HA
and anti-Myc primary antibodies (Santa Cruz Biotechnology) and
tetramethylrhodamine isothiocyanate (TRITC) and ﬂuorescein isothi-
ocyanate (FITC) conjugated secondary antibodies (Dako Diagnostics
BV, Denmark). Cells were analyzed on a Zeiss confocal laser scanning
microscope (LSM510).2.4. Histone H3 pull down assay
Mouse histone H3 cDNA cloned into the pGEX-4T-3 (Amersham
Pharmacia Biotech) bacterial expression vector was a kind gift from
Dr. Y. Shinkai (Department of Cell Biology, Kyoto University,
Japan). The isolation and puriﬁcation of the fusion protein was per-
formed as described previously [21]. Recombinant proteins were
expressed in Escherichia coli and puriﬁed using glutathione beads.
The concentration was quantiﬁed by Coomassie Brilliant Blue R-250
staining. Equal concentrations of the GST-H3 recombinant protein
were incubated with cell extracts from uE cells transfected with
Myc-SUV39H1 with or without HA-Evi1. The complexes were incu-
bated overnight at 4 C, washed with ice-cold lysis buﬀer and separated
on an 8% SDS–PAGE gel. Detection with antibodies was performed as
described above.2.5. Luciferase reporter assays
The luciferase reporter assays were performed as described previ-
ously [26]. In short, uE cells were grown in 24-well plates at a density
of 1 · 105 cells per well and transfected with 300 ng 4xGAL-TK-Luc,
100 ng pcDNA3-DBD-Evi1, 300 ng pRSVLacZ and various concen-
trations of pCMV-SUV39H1. The total amount of plasmid DNA
was normalized to 1 lg using empty pCMV expression vector.++++ +- - --FLAG-Evi1
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and its various mutants were transfected with full length FLAG-Evi1.
were detected by WB analysis using an anti-Myc antibody. Ten percent
ing GST-H3 (left panel) or GST alone (right panel) from cell extracts
were detected by WB. Puriﬁed GST-H3 or GST concentrations were
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3.1. Evi1 interacts with SUV39H1 via its N-terminal zinc ﬁnger
domain
The Evi1 protein has been shown to physically and function-
ally interact with diﬀerent classes of nuclear proteins involved
in transcriptional control [11–13]. To establish whether Evi1
is able to interact with SUV39H1, uE cells were transiently
transfected with Myc-SUV39H1 and HA-Evi1. SUV39H1
and Evi1 complexes were immunoprecipitated using anti-Myc
or anti-HA antibodies. Analysis of these complexes onWestern
blots revealed the presence of Myc-SUV39H1 in HA-Evi1
immunoprecipitates. Likewise, HA-Evi1 could be detected in
Myc-SUV39H1 immunoprecipitates (Fig. 1A). The interaction
is speciﬁc, as only very low background levels of HA-Evi1 or
Myc-SUV39H1 were observed in single transfected cells using
anti-Myc or anti-HA antibodies, respectively. Furthermore,
immunoﬂuorescence analysis and confocal microscopy showed
partial co-localization between Evi1 and SUV39H1 in cells
transiently transfected with both constructs (Fig. 1B). The
results of these experiments illustrate that the two proteins
interact with each other in intact cells.Autoradiograph
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electrophoresis. Equal amounts of histone H3 peptide were present in ea
demonstrated by autoradiography (lower panel).To identify the region of Evi1 required for the interaction
with SUV39H1 we constructed a panel of FLAG-Evi1mutants
(Fig. 1C). Full length Myc-SUV39H1 was only able to interact
with FLAG-Evi1 mutants that contained an intact N-terminal
zinc ﬁnger domain (FLAG-ZF 1–7) or that only missed zinc
ﬁngers 4–7 (FLAG-Evi1D4–7). This indicates that the region
required for interaction is located within the ﬁrst zinc ﬁnger
domain (Fig. 1D).
Our data thus demonstrate an association between Evi1 and
SUV39H1, a member of the histone methyltransferase family
of genes.4. The SET domain of SUV39H1 binds Evi1 and the complex
speciﬁcally interacts with the histone H3 N-terminus
SUV39H1 is a transcriptional repressor that methylates his-
tone residues, but requires speciﬁc DNA binding proteins for
its recruitment to particular promoter regions [27]. To identify
which domain of SUV39H1 is responsible for the interaction
with Evi1, we carried out co-immunoprecipitation experiments
with full length HA-Evi1 and various Myc-SUV39H1 mutantsHistone H3
FLAG-Evi1
Myc-SUV39H1
+ +- -
+ +- -
Coomassie
Autoradiograph
Histone H3
1 2 3Lane 4
IgG
en SUV39H1 is present. Evi1 does not interfere with SUV39H1 histone
or anti-Myc antibodies from cells transfected with FLAG-Evi1/Myc-
e assay. Closed arrow heads indicate puriﬁed FLAG-Evi1; open arrow
ted in each lane by an arrow. Myc-SUV39H1 was immunoprecipitated
methylation is demonstrated by autoradiography in the middle panel.
ned by WB. (B) FLAG-Evi1 and Myc-SUV39H1 were transfected
combination were analyzed in an HMTase assay. The upper ﬁgure
G-Evi1 in lanes 2 and 3 (closed arrow heads). Myc-SUV39H1 are in
r with the IgG heavy chain. Lane 1 is a control precipitation using an
e and an HMTase assay was performed followed by SDS–PAGE
ch lane (upper ﬁgure). Speciﬁc H3 methylations in the lysates were
Evi1Gal4DBD
4X Gal4AD LucTk promoter
Gal4DBDGal4-DBD
Gal4-DBD-Evi1
4XGal4AD-TK-Luc
SUV39H1
D. Spensberger, R. Delwel / FEBS Letters 582 (2008) 2761–2767 2765(Fig. 2A). SUV39H1 contains several functional domains that
have all been shown to play an important role in the function
of the protein. Our results illustrate that absence of the SET
domain, which is responsible for the methylation of H3-K9,
completely abolishes the interaction with Evi1 (Fig. 2B). In
contrast, co-expression with Myc-SUV39H1-D chromo or
Myc-SUV39H1 constructs, which retain the SET domain, pre-
served the interaction with Evi1.
Since H3-K9 is known to be a speciﬁc target of the
SUV39H1 enzyme, we investigated if SUV39H1 and Evi1
can form a complex at the H3 tail using GST-pull down exper-
iments with GST recombinant protein fused to the histone H3
N-terminal tail (amino acids 1–57). uE cells transfected with
HA-Evi1 alone or in combination with Myc-SUV39H1 were
lysed and incubated with equal concentrations of GST-H3
(Fig. 2C). Staining with an anti-HA antibody revealed the
presence of Evi1 in the samples that also contained SUV39H1,
while no HA-Evi1 signal was observed in the control samples
with HA-Evi1 and GST-H3 alone. Collectively, these data
demonstrate that the Evi1–SUV39H1 complex is able to bind
the histone H3 tail in vitro, which may aﬀect the expression
of putative Evi1 target genes.
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Fig. 4. SUV39H1 enhances the transcriptional repression activity of
Evi1. (A) Schematic representation of the constructs used for the
luciferase assay: Gal4 DNA binding domain (Gal4-DBD), Evi1 fused
to the Gal4 DNA binding domain (Gal4-DBD-Evi1), Luciferase
reporter plasmid with four Gal4 binding sites upstream of the
thymidine kinase promoter (4xGal4AD-TK-Luc). (B) Cells were co-
transfected with 4xGal4AD-TK-Luc, Gal4-DBD-Evi1 and diﬀerent
concentrations of the SUV39H1 expression plasmid; concentrations
shown are in micrograms of DNA. All luciferase assays were
performed in triplicates in two independent experiments. (C) Lucifer-
ase experiment using SUV39H1DSET instead of SUV39H1. The
experimental set-up was as described above.5. The Evi1–SUV39H1 complex displays methyltransferase
activity, however Evi1 does not interfere with SUV39H1
activity
In accordance with the ‘‘histone code’’, modiﬁcations of the
histone H3 N-terminus inﬂuence the chromatin state, result-
ing in either silenced heterochromatin, due to speciﬁc lysine
methylation, or active euchromatin, due to acetylation.
SUV39H1 possesses histone methyltransferase activity speciﬁc
for H3-K9 [19]. To investigate whether the Evi1–SUV39H1
complex retains this activity, we transfected uE cells with
FLAG-Evi1, Myc-SUV39H1 or with both constructs. Immu-
noprecipitation of SUV39H1 from single transfected cells
clearly showed methylation of histone H3 as expected (Fig.
3A, lane 1), while immunoprecipitated Evi1 alone did not
show any activity (Fig. 3A, lane 2). Notably, Evi1 immuno-
precipitated from cells transfected with both constructs
showed a clear methylation signal, indicating that the Evi1–
SUV39H1 complex possesses methyltransferase activity (Fig.
3A, lane 3).
The in vitro binding analyses (Fig. 2) suggest that the inter-
action between Evi1 and SUV39H1 requires a speciﬁc region
within the SET domain of SUV39H1. As this domain is also
required for the enzymatic activity of SUV39H1 [27], we asked
the question if the interaction between Evi1 and SUV39H1
might inﬂuence its histone methyltransferase activity. uE cells
were transfected with Myc-SUV39H1 or FLAG-Evi1 and the
proteins were subsequently immunoprecipitated with anti-
Myc or anti-FLAG antibodies (Fig. 3B, upper panel). Puriﬁed
immunoprecipitates were combined and the methyltransferase
activity of the complexes was analyzed in HMTase assays (Fig.
3B; lower panel). The results demonstrate that the activity of
Myc-SUV39H1 is unchanged in the presence of the FLAG-
Evi1 protein (Fig. 3B, lower panel lane 2) as compared to a
sample without FLAG-Evi1 (Fig. 3B, lower panel lane 3).
Therefore, the interaction between Evi1 and SUV39H1,
although it occurs through the SET domain, appears not to
inﬂuence the histone methyltransferase activity of SUV39H1.6. SUV39H1 binding enhances transcriptional repression by
Evi1
To determine if the interaction between SUV39H1 and Evi1
may directly inﬂuence the transcriptional repression by Evi1,
we performed a luciferase reporter assay. We used the Gal4-
DBD and Gal4-AD-Luc system, which is commonly used to
measure transcriptional activity of interacting proteins
[28,29]. A GAL4-DBD-Evi1 construct in combination with a
Myc-SUV39H1 plasmid and the luciferase reporter gene
(GAL4-AD-Luc) were transiently transfected into uE cells
(Fig. 4A). Expression of low concentrations of Evi1 did not
signiﬁcantly repress luciferase expression (Fig. 4B). However,
cells transfected with GAL4-DBD-Evi1 plus increasing con-
centrations of Myc-SUV39H1 showed signiﬁcant repression
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In contrast, we did not observe signiﬁcant changes in the
repression of the luciferase activity in an experiment in which
the SET domain of SUV39H1 was deleted (Fig. 4C). In sum-
mary, SUV39H1, through its SET domain, cooperates with
Evi1 in vivo and enhances the transcriptional repression activ-
ity of Evi1 in a dose dependent manner.7. Evi1 interacts with selected SET domain containing proteins
SET domains are found in many proteins and consist of a
130 amino acid motif ﬁrst identiﬁed in members of the Poly-
comb group (PcG) and Trithorax group (TrG) of genes [20].
To date, several mammalian SET domain proteins have been
identiﬁed and shown to associate directly or indirectly with
chromatin [15,29]. We performed immunoprecipitation assays
with two other known methyltransferase proteins, as the ami-
no acid alignment of the SET domains showed high conserva-
tion between SUV39H1, G9a and SET9 (Fig. 5A).
HA-Evi1 was co-transfected with Myc-SET9, FLAG-G9a
or Myc-SUV39H1. Complexes were immunoprecipitated with
anti-FLAG/anti-Myc antibodies and analyzed for the presence
of Evi1. The experiment in Fig. 5B demonstrates that FLAG-G9a
(lane 2) and SUV39H1 (lane 3) each form a complex with Evi1,
whereas Myc-SET9 did not show any interaction with HA-
Evi1 (lane 1). No HA-Evi1 was detected in immunoprecipita-
tion experiments in the absence of anti-FLAG/anti-Myc
antibody (beads only; lane 4). Similarly, when anti-HA was
used for the immunoprecipitation experiments, only G9a and
SUV39H1 could be detected by anti-FLAGWestern blot anal-
ysis (data not shown).To conﬁrm that the enzymatic activity of G9a could be spe-
ciﬁcally precipitated in a complex with Evi1, we performed an
HMTase assay on H3-histones using HA-Evi1/FLAG-G9a
transfected cells. H3 peptide methylation was demonstrated
with immunoprecipitated FLAG-G9a methyltransferase (Fig.
5C, lane 3), whereas this activity was not detectable when
the same lysate was exposed to beads without anti-FLAG anti-
body (Fig. 5C, lane 5). Using an anti-HA antibody, we immu-
noprecipitated HA-Evi1 with G9a and observed a clear
methylation of puriﬁed H3 (Fig. 5C, lane 1). Autoradiography
revealed no signal in the precipitates obtained in the absence of
either anti-HA or anti-FLAG antibodies (Fig. 5C, lanes 4 and
5) or when no G9a (lane 2) or Evi1 (lane 4) were introduced
into cells.
Taken together, the results presented in this paper illustrate
that Evi1 is able to form a complex with two methyltransfer-
ases, SUV39H1 and G9a, which may aﬀect transcriptional
repression of putative Evi1 target genes.
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